Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mariam Vedadinejad
Response to Imatinib as a Function of Target Kinase Expression in Recurrent Glioblastoma
SpringerPlus
Multidisciplinary
Related publications
Glioblastoma Stem Cells as a New Therapeutic Target for Glioblastoma
Clinical Medicine Insights: Oncology
Oncology
In Silico Analysis of Kinase Expression Identifies WEE1 as a Gatekeeper Against Mitotic Catastrophe in Glioblastoma
Cancer Cell
Cancer Research
Oncology
Cell Biology
Diacylglycerol Kinase Ζ Is a Target to Enhance NK Cell Function
Journal of Immunology
Allergy
Immunology
Remarkable Response in a Case of Recurrent Gastrointestinal Stromal Tumor Treated With Low Dose Imatinib
Journal of Nihon University Medical Association
EphA2 as a Novel Molecular Marker and Target in Glioblastoma Multiforme
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Pregnancy in a Patient With Recurrent Glioblastoma
F1000Research
Genetics
Molecular Biology
Pharmacology
Biochemistry
Microbiology
Immunology
Medicine
Toxicology
Pharmaceutics
Protein Kinase C as a Therapeutic Target
Clinical Cancer Research
Cancer Research
Oncology
Response to MEK Inhibition With Trametinib and Tyrosine Kinase Inhibition With Imatinib in Multifocal Histiocytic Sarcoma
Haematologica
Hematology
Hitting the Target: Measuring EGFR Response to Tyrosine Kinase Inhibitors
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology